510(k) Report

510(k) · Cleared

Cleared

Esa Leadcare II Lead Control

K063398510(k) TraditionalCleared Dec 5, 200626-day reviewClass I21 CFR 862.3280

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Bionostics, Inc. · DIF Drug Mixture Control Materials

Cleared on Dec 5, 2006 as substantially equivalent to K830234 (Kaulson Laboratories, Inc., 1983) after a 26-day review. Its family tree reaches back 1 generation to 1983.

Decided
Dec 5, 2006
Review
26 days
Class
Class I
Product code
DIF
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K830234 (1983). No later device cites it as a predicate yet.

K830234 · Contox Heavymetals Control · Kaulson Laboratories, Inc. · 1983198019851990199520002005
  1. Root · 1 generation backK830234 Contox Heavymetals ControlKaulson Laboratories, Inc. · 1983
  2. This deviceK063398 Esa Leadcare II Lead ControlBionostics, Inc. · 2006
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K830234Contox Heavymetals ControlKaulson Laboratories, Inc.1983—
0 (this device)K063398Esa Leadcare II Lead ControlBionostics, Inc.2006—
FIG. 1 — Lineage of K063398, 1983–2006Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DIF? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K830234Contox Heavymetals Control
Summary page 1
…Name: LeadCare P1Lead Control Kaulson Labs LeadCare Lead Control 51 0(k): -- K830234 Description: Aqueous solution containing bovine albumin, Lyophilized whole bovine blood with pre-…
Kaulson Laboratories, Inc.1983—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.

How does its category compare?

All DIF devices

DIF Drug Mixture Control Materials: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · DIF

1in 2016

2007: 12008: 22010: 12011: 12012: 32013: 22016: 1
2007high 3 (2012) · low 0 (2009)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DIF

35in 2012

2012: 35 days median
2007high 35 (2012)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DIF

1in 2021

2011: 12013: 12017: 52021: 1
2007high 5 (2017) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DIF

1in 2016

2011: 12012: 32016: 1
2007high 3 (2012) · low 0 (2007)2025

MAUDE reports naming product code DIF, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—00
20082—00
20090—00
20101—00
20111—11
201233503
20132—10
20140—00
20150—00
20161—01
20170—50
20180—00
20190—00
20200—00
20210—10
20220—00
20230—00
20240—00
20250—00
20260—0—

What is it indicated for?

ESA Biosciences LeadCare II Control is intended to be used to monitor and evaluate the analytical performance of the ESA Biosciences LeadCare II Analyzer for the measurement of lead in blood. The use of quality control materials is indicated as an objective assessment of the precision of methods and techniques in use and is an integral part of good laboratory practice. The two levels of lead provided by the controls allow performance monitoring within the clinically important range.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K063398: Esa Leadcare II Lead Control.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K063398

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026